You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
高瓴資本持續重倉生物製藥企業 百濟神州為第二大重倉股
格隆匯 02-15 06:45
格隆匯2月15日丨美國證券交易委員會(SEC)的最新數據顯示,高瓴資本持續重倉生物製藥企業。百濟神州作為生物製藥的頭部企業,也是高瓴資本的第二大重倉股,持有市值從三季度末的6.7億美元漲至四季度末的9.1億美元,漲幅達35.8%。另外,在高瓴資本持倉的全部54家公司中,生物製藥公司佔據25席,可以看出高瓴在該領域的持續深耕和重點佈局。在此次疫情爆發的背景下,醫療健康行業當中的眾多上市公司為新型冠狀病毒肺炎的研究和治療做出了貢獻,創造了巨大社會價值。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account